AstraZeneca, the British-Swedish pharmaceutical conglomerate, denied on Monday that it had breached its contract to supply the European Union with 300 million doses of its Covid-19 vaccine.
“AstraZeneca has fully complied with the Advance Purchase Agreement with the European Commission and will vigorously defend itself in court,” the company said in a written statement issued shortly after the EU executive branch announced that it was taking legal action against AstraZeneca for alleged breaches of its Covid-19 vaccine supply contract, according to the dpa news agency.
“We believe any litigation is without merit,” the statement continued, “and we welcome this opportunity to resolve this dispute as soon as possible.”
According to the company, it expects to deliver 50 million doses to European countries by the end of April, as predicted.
“Vaccines are difficult to manufacture, as evidenced by the supply challenges that several companies in Europe and around the world are experiencing,” AstraZeneca said.
Earlier in the day, European Commission spokesperson Stefan De Keersmaecker stated, “The company (AstraZeneca) has not been able to come up with a reliable strategy to ensure the timely delivery of doses.”
“We want to ensure that a sufficient number of doses that European citizens are entitled to and that have been promised on the basis of the contract are delivered as soon as possible.”